Trill
Antonio Trill, Maglaso CH
Patent application number | Description | Published |
---|---|---|
20120264180 | PROCESS FOR THE BIOLOGIC TREATMENT OF ORGANIC WASTES AND PLANT THEREFOR - Process for the biological treatment of organic wastes, includes a first anaerobic digestion phase and a second aerobic digestion phase in succession, a respective filtration phase of the solid substance being provided between the two digestion phases, a separation phase of the biogas released in the anaerobic digestion phase and a nitrogen recovery phase from the exhaust gases rich in ammoniac substances separated from the aerobic digestion phase. The solid substance coming from each of the filtration phases is separately returned to the respective digestion phase, while the liquid phase coming from the filtration phase downstream of the anaerobic digestion phase is sent to aerobic phase. In the nitrogen recovery phase the gaseous current consisting of exhaust gases rich in ammoniac substances is treated with a solution of carbonic acid supplied in countercurrent in a first gas/liquid contactor to obtain a mixture of nitrogen salts (ammonium bicarbonate, ammonium carbonate, etc.). | 10-18-2012 |
Helen Mary Trill, Harlow GB
Patent application number | Description | Published |
---|---|---|
20120180785 | Pressurized Metered Dose Inhalers - The invention provides a pMDI metering valve comprising at least one component which comprises a desiccant-entrained material, a pMDI closed container system containing a desiccant-entrained material, and a method of stabilising the fine particle mass (FPM) of an inhalation drug formulation emitted by a pMDI closed container system comprising providing a desiccant-entrained material inside the pMDI closed container system so as to be in contact with the formulation therein. | 07-19-2012 |
John J. Trill, King Of Prussia, PA US
Patent application number | Description | Published |
---|---|---|
20090148892 | NOVEL METHODS - This present invention relates to the use of the B1 domain of Protein G as an epitope tag for over-expression of proteins in mammalian cells. | 06-11-2009 |
Thomas Trill, Schildow DE
Patent application number | Description | Published |
---|---|---|
20120237532 | PHARMACEUTICAL FORMULATION CONTAINING IMMUNOGLOBULIN - A set of at least two different protein conjugate preparations, each protein conjugate preparation comprising histidine as a buffering agent and a protein conjugate comprising one or more immunoglobulin moieties conjugated to a carrier protein; wherein the immunoglobulin moieties of each element of said set of protein conjugate preparation have identical complementarity determining regions (CDRs); and wherein different protein conjugate preparations differ in that the immunoglobulin moieties of the protein conjugates have different CDRs. | 09-20-2012 |